- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Therapeutic Dostarlimab monoclonal antibody from the original Jemperli® commercial drug.
Showing all 4 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.07 |
493,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.10 |
1.396,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2025.10 |
1.149,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
2026.03 |
2.154,60 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
